Jianjie Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jianjie Wang has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Danyang Meng
School of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China
2 shared publicationsRongjia Zang
Department of Anesthesiology, The First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang 154002, P.R. China
2 shared publicationsChennan Wang
School of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang 154007, P.R. China
1 shared publication- Erlin Zhang
Key Laboratory for Anisotropy and Texture of Materials, Education Ministry of China, School of Materials Science and Engineering, Northeastern University, Shenyang 110819, China
1 shared publication Hang Dong
Department of Hematology, Shenzhen Yantian District People's Hospital, Shenzhen, Guangdong 518081, P.R. China
1 shared publicationHui Xu
Department of Biochemistry and Molecular Biology, Jiamusi University
1 shared publication
Latest Publications
- Open Access
- 24 April 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1545667
PD-L1 in plasmacytoid dendritic cells promote HBV persistence through disrupting humoral immune response
Objective: To investigate the efficacy of PD-L1 blockade in restoring humoral immune response against HBV.Methods: HBV‐persistent C57BL/6J mice were established through hydrodynamic tail vein injection of 10 µg pAAV‐HBV1.2 plasmid. Subsequently, mice treated i.p. with anti‐PD‐L1 and/or anti‐CTLA‐4 at specified time points, with dosages of 500 µg, 250 µg, and 250 µg, respectively. Additionally, 5 × 105 magnetic bead‐purified plasmacytoid dendritic cells (pDCs) were adoptively transferred i.v. into the acute mouse model followed by anti-PD-L1 treatment. Quantitative real-time PCR was employed to assess the expression levels of costimulatory and tolerogenic molecules in two dendritic cell subsets. Serum HBsAg and HBsAb were measured using ELISA. Flow cytometry was utilized to quantify T follicular helper (Tfh) cells, regulatory T cells (Treg), and germinal center (GC) B cells.Results: PD-L1 blockade markedly enhanced the differentiation of Tfh cells and GC B cells in HBV-persistent C57BL/6J mice, thereby promoting HBV clearance. Additionally, pDCs exhibited an increased capacity to induce immune tolerance, with pDCs isolated from HBV carriers inducing viral persistence. This persistence was effectively counteracted by treatment with anti-PD-L1.Conclusion: pDCs mediate the dysregulation of the humoral immune response to HBV through PD-L1 in chronic hepatitis B infection, highlighting a promising target for the management of chronic HBV.
- 24 April 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1545667
Open AccessPD-L1 in plasmacytoid dendritic cells promote HBV persistence through disrupting humoral immune response
Objective: To investigate the efficacy of PD-L1 blockade in restoring humoral immune response against HBV.Methods: HBV‐persistent C57BL/6J mice were established through hydrodynamic tail vein injection of 10 µg pAAV‐HBV1.2 plasmid. Subsequently, mice treated i.p. with anti‐PD‐L1 and/or anti‐CTLA‐4 at specified time points, with dosages of 500 µg, 250 µg, and 250 µg, respectively. Additionally, 5 × 105 magnetic bead‐purified plasmacytoid dendritic cells (pDCs) were adoptively transferred i.v. into the acute mouse model followed by anti-PD-L1 treatment. Quantitative real-time PCR was employed to assess the expression levels of costimulatory and tolerogenic molecules in two dendritic cell subsets. Serum HBsAg and HBsAb were measured using ELISA. Flow cytometry was utilized to quantify T follicular helper (Tfh) cells, regulatory T cells (Treg), and germinal center (GC) B cells.Results: PD-L1 blockade markedly enhanced the differentiation of Tfh cells and GC B cells in HBV-persistent C57BL/6J mice, thereby promoting HBV clearance. Additionally, pDCs exhibited an increased capacity to induce immune tolerance, with pDCs isolated from HBV carriers inducing viral persistence. This persistence was effectively counteracted by treatment with anti-PD-L1.Conclusion: pDCs mediate the dysregulation of the humoral immune response to HBV through PD-L1 in chronic hepatitis B infection, highlighting a promising target for the management of chronic HBV.
- Open Access
- 12 December 2023
- Published by Spandidos Publications in Oncology Letters
- Vol. 27 (2) , 1-7
Role of interleukin‑32 in cancer progression (Review)
Interleukin (IL)‑32 is induced by pro‑inflammatory cytokines and promotes the release of inflammatory cytokines. Therefore, it can promote inflammatory responses. The present review article summarized the role of the receptors required for IL‑32 action, the biological function of IL‑32 and its mechanism of action in tumors. Moreover, it assessed the significance of aberrant IL‑32 expression in associated diseases and analyzed the effects of IL‑32 on four key types of cancer: Colorectal, gastric, breast and lung. However, the mechanism of action of IL‑32 needs to be further demonstrated by assessing the role of this cytokine in cancer to elucidate novel and reliable targets for future cancer treatments.
- 12 December 2023
- Published by Spandidos Publications in Oncology Letters
- Vol. 27 (2) , 1-7
Open AccessRole of interleukin‑32 in cancer progression (Review)
Interleukin (IL)‑32 is induced by pro‑inflammatory cytokines and promotes the release of inflammatory cytokines. Therefore, it can promote inflammatory responses. The present review article summarized the role of the receptors required for IL‑32 action, the biological function of IL‑32 and its mechanism of action in tumors. Moreover, it assessed the significance of aberrant IL‑32 expression in associated diseases and analyzed the effects of IL‑32 on four key types of cancer: Colorectal, gastric, breast and lung. However, the mechanism of action of IL‑32 needs to be further demonstrated by assessing the role of this cytokine in cancer to elucidate novel and reliable targets for future cancer treatments.
- 14 March 2022
- Published by Wiley in Rare Metals
- Vol. 41 (6) , 1921-1932
Tribocorrosion behavior of antibacterial Ti–Cu sintered alloys in simulated biological environments
Ti–Cu alloys have strong antibacterial properties, high strength and excellent corrosion resistance, which might be used in orthopedic and dental implants. In this paper, the tribocorrosion behaviors of Ti–Cu alloy with different Cu contents were investigated in four simulated biological environments compared with cp‐Ti. The results showed that Ti–Cu sintered alloy exhibited higher corrosion resistance, lower coefficient friction and wear loss than cp‐Ti in all tested solutions due to the formation of fine and homogeneously distributed Ti 2 Cu phase, especially in solution with lower F ion and pH. High Cu content and extrusion process improved the corrosion resistance and the wear resistance because of high Ti 2 Cu phase fraction and fine grain size. However, aggressive solution, such as the solution with lower F ion and pH, accelerated wear in comparison with other solutions for cp‐Ti and Ti–Cu sintered alloys. Scanning electron microscope (SEM) surface morphology demonstrated that the wear mechanism of cp‐Ti during tribocorrosion process was mainly abrasive wear and adhesive wear while that of Ti–Cu alloy was abrasive wear. In summary, Ti–Cu sintered alloys showed much better tribocorrosion property than cp‐Ti, which shows great potential application in condition for wear and corrosion resistance.
- 14 March 2022
- Published by Wiley in Rare Metals
- Vol. 41 (6) , 1921-1932
Tribocorrosion behavior of antibacterial Ti–Cu sintered alloys in simulated biological environments
Ti–Cu alloys have strong antibacterial properties, high strength and excellent corrosion resistance, which might be used in orthopedic and dental implants. In this paper, the tribocorrosion behaviors of Ti–Cu alloy with different Cu contents were investigated in four simulated biological environments compared with cp‐Ti. The results showed that Ti–Cu sintered alloy exhibited higher corrosion resistance, lower coefficient friction and wear loss than cp‐Ti in all tested solutions due to the formation of fine and homogeneously distributed Ti 2 Cu phase, especially in solution with lower F ion and pH. High Cu content and extrusion process improved the corrosion resistance and the wear resistance because of high Ti 2 Cu phase fraction and fine grain size. However, aggressive solution, such as the solution with lower F ion and pH, accelerated wear in comparison with other solutions for cp‐Ti and Ti–Cu sintered alloys. Scanning electron microscope (SEM) surface morphology demonstrated that the wear mechanism of cp‐Ti during tribocorrosion process was mainly abrasive wear and adhesive wear while that of Ti–Cu alloy was abrasive wear. In summary, Ti–Cu sintered alloys showed much better tribocorrosion property than cp‐Ti, which shows great potential application in condition for wear and corrosion resistance.
- 29 January 2022
- Published by International Heart Journal (Japanese Heart Journal) in International Heart Journal
- Vol. 63 (1) , 8-14
Effects of Recombinant Human Brain Natriuretic Peptide in Patients with Acute Pulmonary Embolism Complicated with Right Ventricular Dysfunction Who Underwent Catheter-Directed Therapy
Acute pulmonary embolism (PE) remains a significant cause of cardiovascular morbidity and mortality worldwide. Brain natriuretic peptide (BNP) combined with catheter-directed therapy (CDT) may improve right ventricular (RV) dysfunction and stabilize hemodynamics in acute PE. We retrospectively studied 159 patients with confirmed acute PE who were treated with CDT and admitted to the intensive care unit of our department between September 2016 and May 2020. The patients were divided into the control group and the rhBNP group based on whether to receive recombinant human BNP treatment (rhBNP) or not. The basic characteristics of the patients between the control group and the rhBNP group was systematically compared during admission and follow-up. Risk factors for all-cause mortality within 30 days were determined using multivariate logistic regression analysis. Respiratory rate was found to be significantly lower in the rhBNP group than in the control group. Patients in the rhBNP group had significantly lower levels of white blood cell, C-reactive protein (CRP), D-dimers, troponin I, creatinine, and N-terminal (NT) -proBNP compared with those in the control group. Levels of tricuspid annular plane systolic excursion were significantly higher in the rhBNP group than in the control group. The percentage of patients with rehospitalization readmission due to PE differed significantly between the control group and the rhBNP group. On the basis of the multivariate regression analysis, CRP, creatinine, troponin I, and NT-proBNP were independent factors of all-cause mortality in 30 days. rhBNP is effective in the treatment of patients with RV dysfunction caused by acute PE who underwent CDT, which may be an alternative treatment option for improving clinical prognosis.
- 29 January 2022
- Published by International Heart Journal (Japanese Heart Journal) in International Heart Journal
- Vol. 63 (1) , 8-14
Effects of Recombinant Human Brain Natriuretic Peptide in Patients with Acute Pulmonary Embolism Complicated with Right Ventricular Dysfunction Who Underwent Catheter-Directed Therapy
Acute pulmonary embolism (PE) remains a significant cause of cardiovascular morbidity and mortality worldwide. Brain natriuretic peptide (BNP) combined with catheter-directed therapy (CDT) may improve right ventricular (RV) dysfunction and stabilize hemodynamics in acute PE. We retrospectively studied 159 patients with confirmed acute PE who were treated with CDT and admitted to the intensive care unit of our department between September 2016 and May 2020. The patients were divided into the control group and the rhBNP group based on whether to receive recombinant human BNP treatment (rhBNP) or not. The basic characteristics of the patients between the control group and the rhBNP group was systematically compared during admission and follow-up. Risk factors for all-cause mortality within 30 days were determined using multivariate logistic regression analysis. Respiratory rate was found to be significantly lower in the rhBNP group than in the control group. Patients in the rhBNP group had significantly lower levels of white blood cell, C-reactive protein (CRP), D-dimers, troponin I, creatinine, and N-terminal (NT) -proBNP compared with those in the control group. Levels of tricuspid annular plane systolic excursion were significantly higher in the rhBNP group than in the control group. The percentage of patients with rehospitalization readmission due to PE differed significantly between the control group and the rhBNP group. On the basis of the multivariate regression analysis, CRP, creatinine, troponin I, and NT-proBNP were independent factors of all-cause mortality in 30 days. rhBNP is effective in the treatment of patients with RV dysfunction caused by acute PE who underwent CDT, which may be an alternative treatment option for improving clinical prognosis.
- Open Access
- 6 September 2019
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 39 (9)
miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3
MicroRNA plays an important role in gastric cancer (GC) development, while the function of miR-497-5p in this disease remains unknown. In the present study, we demonstrated miR-497-5p as a tumor suppressive microRNA in GC. miR-497-5p was down-regulated in GC tissues and its expression was associated with the disease stage. Inhibition of miR-497-5p promoted GC cell proliferation and growth. By contrast, miR-497-5p ectopic expression suppressed the proliferation and growth of GC cells. In addition, miR-497-5p inhibited DNA synthesis and enhanced apoptosis in GC cells. The cell cycle progression was suppressed by miR-497-5p. Mechanistically, miR-497-5p directly targeted and suppressed the expression of pyruvate dehydrogenase kinase 3 (PDK3), which is highly expressed in GC tissues. Over-expression of PDK3 promoted the proliferation of GC cells. Our study revealed that miR-497-5p inhibited GC cell proliferation and growth via targeting PDK3.
- 6 September 2019
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 39 (9)
Open AccessmiR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3
MicroRNA plays an important role in gastric cancer (GC) development, while the function of miR-497-5p in this disease remains unknown. In the present study, we demonstrated miR-497-5p as a tumor suppressive microRNA in GC. miR-497-5p was down-regulated in GC tissues and its expression was associated with the disease stage. Inhibition of miR-497-5p promoted GC cell proliferation and growth. By contrast, miR-497-5p ectopic expression suppressed the proliferation and growth of GC cells. In addition, miR-497-5p inhibited DNA synthesis and enhanced apoptosis in GC cells. The cell cycle progression was suppressed by miR-497-5p. Mechanistically, miR-497-5p directly targeted and suppressed the expression of pyruvate dehydrogenase kinase 3 (PDK3), which is highly expressed in GC tissues. Over-expression of PDK3 promoted the proliferation of GC cells. Our study revealed that miR-497-5p inhibited GC cell proliferation and growth via targeting PDK3.
- Open Access
- 31 July 2014
- Published by The Korean Society of Applied Pharmacology in Biomolecules & Therapeutics
- Vol. 22 (4) , 341-346
Antitumor and Apoptosis Induction Effects of Paeonol on Mice Bearing EMT6 Breast Carcinoma
Paeonol is a major phenolic micromolecular component of Moutan cortex Radicis, a traditional Chinese Medicine. It has shown antitumor effects in previous studies; however, the underlying mechanisms remain unknown. This study investigated the mechanism by giving treatments of placebo, cyclophosphamide, paeonol of 150 and 300 mg/kg to 4 groups of mice bearing EMT6 breast cancer. Apoptosis in tumor cells were confirmed by morphology analysis, including hematoxylin, eosin staining and TUNEL staining. The results showed that the weight of EMT6 breast tumor was significantly reduced in the groups treated with both 150 and 300 mg/kg of paeonol. Immunohistochemical and Western blot results showed that the expression of Bcl-2 was down-regulated while the expression of Bax, caspase 8 and caspase 3 was up-regulated respectively. These results suggest that paeonol exhibits antitumor effects and the mechanism of the inhibition is via induction of apoptosis, regulation of Bcl-2 and Bax expression, and activation of caspase 8 and caspase 3.
- 31 July 2014
- Published by The Korean Society of Applied Pharmacology in Biomolecules & Therapeutics
- Vol. 22 (4) , 341-346
Open AccessAntitumor and Apoptosis Induction Effects of Paeonol on Mice Bearing EMT6 Breast Carcinoma
Paeonol is a major phenolic micromolecular component of Moutan cortex Radicis, a traditional Chinese Medicine. It has shown antitumor effects in previous studies; however, the underlying mechanisms remain unknown. This study investigated the mechanism by giving treatments of placebo, cyclophosphamide, paeonol of 150 and 300 mg/kg to 4 groups of mice bearing EMT6 breast cancer. Apoptosis in tumor cells were confirmed by morphology analysis, including hematoxylin, eosin staining and TUNEL staining. The results showed that the weight of EMT6 breast tumor was significantly reduced in the groups treated with both 150 and 300 mg/kg of paeonol. Immunohistochemical and Western blot results showed that the expression of Bcl-2 was down-regulated while the expression of Bax, caspase 8 and caspase 3 was up-regulated respectively. These results suggest that paeonol exhibits antitumor effects and the mechanism of the inhibition is via induction of apoptosis, regulation of Bcl-2 and Bax expression, and activation of caspase 8 and caspase 3.